Showing results (101-110 of 156) with videos related to
Sort By:
Pageof 16
Frontiers in Endocrinology|August 30, 2021
Diabetes in Patients With Heart Failure With Reduced Ejection Fraction During Hospitalization: A Retrospective Observational StudyYiling Zhou, Miye Wang, Si Wang, et al.JAMA Pediatrics|September 15, 2025
Digital Health Interventions in Pediatric Perioperative Care: A Network Meta-AnalysisZiyue Luo, Ruihao Zhou, Kailei Nong, et al.Annals of Internal Medicine|April 11, 2022
Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Heart Failure : A Systematic Review and Meta-analysisXinyu Zou, Qingyang Shi, Per Olav Vandvik, et al.Frontiers in Pharmacology|March 12, 2025
Time-varying cost-effectiveness analysis of sodium-glucose cotransporter-2 inhibitors in Chinese patients with heart failure and reduced ejection fraction: A microsimulation of the real-world populationXinyu Zou, Xingchen He, Qingyang Shi, et al.Diabetes, Obesity & Metabolism|November 24, 2023
Sex-specific associations between skeletal muscle mass and incident diabetes: A population-based cohort studyDan Liu, Nan Li, Yiling Zhou, et al.Expert Opinion on Drug Safety|January 9, 2020
Cefoperazone-sulbactam and risk of coagulation disorders or bleeding: a retrospective cohort studyWen Wang, Yanmei Liu, Chuan Yu, et al.NPJ Digital Medicine|February 3, 2026
Digital health interventions for perioperative patient-reported outcomes: a network meta-analysisZiyue Luo, Ruihao Zhou, Jingwen Wei, et al.BMJ (Clinical Research Ed.)|May 4, 2022
PCSK9 inhibitors and ezetimibe with or without statin therapy for cardiovascular risk reduction: a systematic review and network meta-analysisSafi U Khan, Siva H Yedlapati, Ahmad N Lone, et al.Frontiers in Pharmacology|December 13, 2021
Guideline Adherence of β-blocker Initiating Dose and its Consequence in Hospitalized Patients With Heart Failure With Reduced Ejection FractionYiling Zhou, Yuping Zeng, Si Wang, et al.BMJ Medicine|November 22, 2024
Sodium-glucose co-transporter-2 inhibitors in patients with chronic kidney disease with or without type 2 diabetes: systematic review and meta-analysisXinyu Zou, Qingyang Shi, Per Olav Vandvik, et al.Pageof 16